Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)

Completed · Phase 3 · Has a placebo group

Conditions studied: Inflammation

In brief

The purpose of this phase III study is to determine the safety and efficacy of difluprednate in the treatment of inflammation following ocular surgery.

Key facts

Study ID

NCT00616993

Run by

Sirion Therapeutics, Inc.

People needed

120

Starts

2008-01-01

Expected to finish

2008-03-01

Last updated by the study team

2011-07-01

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled for unilateral ocular surgery.

You may not qualify if…

• Systemic administration of any corticosteroid or immunosuppressive drug in the 2 weeks prior to study enrollment.

Where it is running

• Eye Associates of Fort Myers — Fort Myers, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.